Nr5a2 amplification, observed in lung cancer tissues (Figure 1, 2, 3, 4, 5, 6A‐B), is associated with poor OS and PFS (Figure 1, 2, 3, 4, 5, 6C ‐D). Here, NR5A2 is linked to lung cancer.